-+ 0.00%
-+ 0.00%
-+ 0.00%

Stephens & Co. Maintains Equal-Weight on Health Catalyst, Lowers Price Target to $1.75

Benzinga·05/12/2026 13:35:42
Listen to the news
Stephens & Co. analyst Jeff Garro maintains Health Catalyst (NASDAQ:HCAT) with a Equal-Weight and lowers the price target from $2 to $1.75.